1.
|
14 p, 1.2 MB |
Systemic oncological treatments in patients with advanced pancreatic cancer: a scoping review and evidence map
/
Salazar, Josefina (Institut d'Investigació Biomèdica Sant Pau) ;
Bracchiglione, Javier (Institut d'Investigació Biomèdica Sant Pau) ;
Acosta-Dighero, Roberto (Universidad de Valparaíso, Chile) ;
Meza, Nicolas (Universidad de Valparaíso, Chile) ;
Meade, Adriana-G. (Institut d'Investigació Biomèdica Sant Pau) ;
María Jesús Quintana (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Requeijo, Carolina (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez-Grijalva, Gerardo (Institut d'Investigació Biomèdica Sant Pau) ;
Santero, Marilina (Institut d'Investigació Biomèdica Sant Pau) ;
Selva, Anna (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Bonfill, Xavier (Universitat Autònoma de Barcelona. Departament de Pediatria, Obstetrícia i Ginecologia i Medicina Preventiva i Salut Pública) ;
Appropriateness of Systemic Oncological Treatments for Advanced Cancer (ASTAC) Research Group
Purpose: To identify, describe, and organise currently available evidence regarding systemic oncological treatments (SOTs) (chemotherapy, targeted/biological therapies, and immunotherapy) compared to best supportive care (BSC) for patients with advanced pancreatic cancer (PC). [...]
2023 - 10.1007/s00520-022-07564-8
Supportive Care in Cancer, Vol. 31 Núm. 2 (January 2023)
3 documents
|
|
2.
|
|
Recent advances in the management of patients with non-muscle-invasive bladder cancer using a multidisciplinary approach : Practical recommendations from the spanish oncology genitourinary (sogug) working group
/
Rubio-briones, J. ;
Algaba, Ferran (Institut d'Investigació Biomèdica Sant Pau) ;
Gallardo, Eduard (Parc Taulí Hospital Universitari. Institut d'Investigació i Innovació Parc Taulí (I3PT)) ;
Marcos-rodríguez, J.A. (Hospital Universitario Virgen Macarena (Sevilla, Andalusia)) ;
Climent, M.Á. (Medical Oncology Service. Fundación Instituto Valenciano de Oncología) ;
Gomez-Caamaño, Antonio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Vicente, A.M.G. ;
Maroto, Pablo (Institut d'Investigació Biomèdica Sant Pau) ;
Antolín, A.R. ;
Sanz, J. ;
González, M.A.V. ;
Del Alba, A.G. ;
Moreno, A.J.C. ;
González-Haba, E.. ;
González-peramato, P. ;
Espinós, E.L. ;
López-beltran, A. ;
Pelechano, P. ;
Garrido, M. ;
Sarrió, R.G. ;
Zapatero, A. ;
Arranz, J.Á. ;
Universitat Autònoma de Barcelona
On the basis of the discussion of the current state of research on relevant topics of non-muscle-invasive bladder cancer (NMIBC) among a group of experts of the Spanish Oncology Gen-itourinary (SOGUG) Working Group, recommendations were proposed to overcome the challenges posed by the management of NMIBC in clinical practice. [...]
2021 - 10.3390/cancers13194762
Cancers, Vol. 13 Núm. 19 (October 2021) , p. 4762
|
|
3.
|
|
Pretreatment tissue TCR repertoire evenness is associated with complete pathologic response in patients with NSCLC receiving neoadjuvant chemoimmunotherapy
/
Casarrubios, M. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Cruz-Bermúdez, A. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Nadal, E. (Institut Català d'Oncologia. L'Hospitalet de Llobregat) ;
Insa, Amelia (Hospital Clínic Universitari (València)) ;
del Rosario García Campelo, M. (Complejo Hospitalario Universitario de A Coruña) ;
Lázaro, M. (Hospital Universitario de Vigo) ;
Dómine Gómez, Manuel (Hospital Universitario Fundación Jiménez Díaz) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez-Abreu, D. (Hospital Insular de Gran Canaria) ;
Martínez-Martí, A. (Vall d'Hebron Institut d'Oncologia) ;
de Castro-Carpeño, J. (Hospital Universitario La Paz (Madrid)) ;
Cobo, M. (Hospital Regional Universitario de Málaga) ;
López-Vivanco, G. (Hospital Universitario de Cruces (Barakaldo, País Basc)) ;
Del Barco, E. (Hospital Universitario de Salamanca) ;
Caro, R.B. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ;
Viñolas, N. (Hospital Clínic i Provincial de Barcelona) ;
Aranda, I.B. (Hospital Universitario Reina Sofía (Córdoba, Espanya)) ;
Viteri, Santiago (Instituto Oncológico Dr. Rosell. Hospital Universitario Quiron Dexeus. Grupo QuironSalud) ;
Massuti, B. (Hospital General Universitario de Alicante (Alacant, País Valencià)) ;
Barquín, M. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Laza-Briviesca, R. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Sierra-Rodero, B. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Parra, E.R. (Department of Translational Molecular Pathology. The University of Texas. MD Anderson Cancer Center) ;
Sanchez-Espiridion, B. (Department of Translational Molecular Pathology. The University of Texas. MD Anderson Cancer Center) ;
Rocha, P. (Department of Translational Molecular Pathology. The University of Texas. MD Anderson Cancer Center) ;
Kadara, H. (Department of Translational Molecular Pathology. The University of Texas. MD Anderson Cancer Center) ;
Wistuba, I.I. (Department of Translational Molecular Pathology. The University of Texas. MD Anderson Cancer Center) ;
Romero, A. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Calvo, V. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda) ;
Provencio, M. (Servicio de Oncología Médica. Instituto de Investigación Sanitaria Puerta de Hierro-Segovia de Arana (IDIPHISA). Hospital Universitario Puerta de Hierro-Majadahonda)
Purpose: Characterization of the T-cell receptor (TCR) repertoire may be a promising source for predictive biomarkers of pathologic response to immunotherapy in locally advanced non-small cell lung cancer (NSCLC). [...]
2021 - 10.1158/1078-0432.CCR-21-1200
Clinical Cancer Research, Vol. 27 Núm. 21 (November 2021) , p. 5878-5890
|
|
4.
|
15 p, 607.8 KB |
PD-L1 testing and clinical management of newly diagnosed metastatic non-small cell lung cancer in Spain : MOREL study
/
Rubio-Viqueira, B. (Department of Medical Oncology. Quirónsalud Madrid Hospital. Pozuelo de Alarcón) ;
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Lázaro, M. (Department of Medical Oncology. Álvaro Cunqueiro University Hospital) ;
Estévez, S.V. (Department of Medical Oncology. Lucus Augusti University Hospital) ;
Córdoba-Ortega, J.F. (Department of Medical Oncology. Arnau de Vilanova University Hospital) ;
Maiques, I.M. (Department of Medical Oncology. Doctor Peset University Hospital) ;
González, J.G. (Department of Medical Oncology. University Clinical Hospital of Santiago de Compostela) ;
Cordellat, A.B. (Department of Medical Oncology. Hospital General Universitario de Valencia. Ciberonc) ;
Valdivia-Bautista, J. (Department of Medical Oncology. Virgen de Las Nieves University Hospital) ;
Arenas, C.G. (Department of Medical Oncology. Msd) ;
Sánchez Torres, J.M. (Department of Medical Oncology. La Princesa University Hospital)
Aim: To describe the clinical management and PD-L1 testing of patients with newly diagnosed stage IV non-small cell lung cancer (NSCLC) without driver mutations in Spain. Methods: Multicenter, retrospective study. [...]
2021 - 10.2217/lmt-2021-0008
Lung Cancer Management, Vol. 10 Núm. 4 (december 2021) , p. LMT53
|
|
5.
|
17 p, 1.0 MB |
Management of localized muscle-invasive bladder cancer from a multidisciplinary perspective : Current position of the Spanish oncology genitourinary (Sogug)working group
/
Gomez-Caamaño, Antonio (Hospital Clínico Universitario (Santiago de Compostela, Galícia)) ;
Vicente, A.M.G. (Nuclear Medicine Department. University General Hospital) ;
Maroto, Pabo (Institut d'Investigació Biomèdica Sant Pau) ;
Antolín, A.R. (Hospital Universitario 12 de Octubre (Madrid)) ;
Sanz, J. (Clínica Universidad de Navarra) ;
González, M.A.V. (Hospital Clínic Universitari (València)) ;
Climent, M.Á. (Fundació Institut Valencià d'Oncologia)
This review presents challenges and recommendations on different aspects related to the management of patients with localized muscle-invasive bladder cancer (MIBC), which were discussed by a group of experts of a Spanish Oncology Genitourinary (SOGUG) Working Group within the framework of the Genitourinary Alliance project (12GU). [...]
2021 - 10.3390/curroncol28060428
Current Oncology, Vol. 28 Núm. 6 (december 2021) , p. 5084-5100
|
|
6.
|
16 p, 758.5 KB |
Pd-(L)1 inhibitors as monotherapy for the first-line treatment of non-small-cell lung cancer patients with high pd-l1 expression : A network meta-analysis
/
Majem, Margarita (Institut d'Investigació Biomèdica Sant Pau) ;
Cobo, M. (Medical Oncology. Hospital Regional Universitario de Málaga) ;
Isla, Dolores (Hospital Clínico Universitario "Lozano Blesa" de Zaragoza) ;
Marquez-Medina, D. (Medical Oncology. University Hospital Miguel Servet) ;
Rodriguez-Abreu, D. (Medical Oncology. Hospital Universitario Insular de Gran Canaria) ;
Casal-Rubio, J. (Medical Oncology Service. Hospital Álvaro Cunqueiro) ;
Bueno, T.M. (Institut Germans Trias i Pujol. Hospital Universitari Germans Trias i Pujol) ;
Bernabé-Caro, R. (Medical Oncology Department. Hospital Virgen del Rocío) ;
Parente, D.P. (Medical Affairs Department. Roche Farma S.A) ;
Ruiz-Gracia, P. (Medical Affairs Department. Roche Farma S.A) ;
Arroyo, M.M. (Medical Affairs Department. Roche Farma S.A) ;
Paz-Ares, L. (Hospital Universitario 12 de Octubre (Madrid))
Programmed cell death-ligand 1 (PD-L1) has emerged as a potential biomarker for selec-tion of patients more likely to respond to immunotherapy and as a prognostic factor in non-small cell lung cancer (NSCLC). [...]
2021 - 10.3390/jcm10071365
Journal of clinical medicine, Vol. 10 Núm. 7 (april 2021) , p. 1365
|
|
7.
|
16 p, 2.7 MB |
Safety and Efficacy of an Oncolytic Adenovirus as an Immunotherapy for Canine Cancer Patients
/
Martín-Carrasco, Clara (Universidad Alfonso X el Sabio. Hospital Clínico Veterinario) ;
Delgado-Bonet, Pablo (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX)) ;
Tomeo-Martín, Beatriz Davinia (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX)) ;
Pastor Milán, Josep (Universitat Autònoma de Barcelona. Fundació Hospital Clínic Veterinari) ;
de la Riva, Claudia (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX)) ;
Palau-Concejo, Paula (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX)) ;
del Castillo, Noemí (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX)) ;
Garcia-Castro, Javier (Instituto de Salud Carlos III) ;
Perisé-Barrios, Ana Judith (Universidad Alfonso X el Sabio. Unidad de Investigación Biomédica (UIB-UAX))
The use of oncolytic virus is an innovative approach that has shown promising results as a treatment in oncology. Epithelial-derived tumors are the most frequent neoplasms in dogs, but gold standard therapies can be highly invasive procedures. [...]
2022 - 10.3390/vetsci9070327
Veterinary Sciences, Vol. 9 (june 2022)
|
|
8.
|
16 p, 3.3 MB |
Prediction of combination therapies based on topological modeling of the immune signaling network in multiple sclerosis
/
Bernardo-Faura, Martí (Centre de Recerca en Agrigenòmica) ;
Rinas, Melanie (Rwth Aachen University. Joint Research Center for Computational Biomedicine) ;
Wirbel, Jakob (Rwth Aachen University. Joint Research Center for Computational Biomedicine) ;
Pertsovskaya, Inna (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Pliaka, Vicky (School of Mechanical Engineering, National Technical University of Athens) ;
Messinis, Dimitris E. (ProtATonce) ;
Vila, Gemma (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Sakellaropoulos, Theodore (National Technical University of Athens) ;
Faigle, Wolfgang (University of Zurich) ;
Stridh, Pernilla (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Behrens, Janina R. (Charité University Medicine Berlin. NeuroCure Clinical Research Center and Department of Neurology) ;
Olsson, Tomas (Karolinska Institutet (Estocolm, Suècia). Department of Clinical Neuroscience) ;
Martin, Roland (University of Zurich) ;
Paul, Friedemann (Charité University Medicine Berlin. NeuroCure Clinical Research Center and Department of Neurology) ;
Alexopoulos, Leonidas G. (ProtATonce) ;
Villoslada, Pablo (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Saez-Rodriguez, Julio (Heidelberg University Hospital (Alemanya))
Multiple sclerosis (MS) is a major health problem, leading to a significant disability and patient suffering. Although chronic activation of the immune system is a hallmark of the disease, its pathogenesis is poorly understood, while current treatments only ameliorate the disease and may produce severe side effects. [...]
2021 - 10.1186/s13073-021-00925-8
Genome Medicine, Vol. 13 (July 2021) , art. 117
|
|
9.
|
11 p, 1.1 MB |
ARIA-EAACI care pathways for allergen immunotherapy in respiratory allergy
/
Bousquet, Jean (MACVIA-France) ;
Pfaar, Oliver (Philipps-Universität Marburg. University Hospital Marburg) ;
Agache, Ioana (Transylvania University Brasov) ;
Bedbrook, Anna (MACVIA-France) ;
Akdis, Cezmi A.. (University of Zurich. Swiss Institute of Allergy and Asthma Research (SIAF)) ;
Canonica, G. Walter (Humanitas Clinical and Research Center IRCCS) ;
Chivato, Tomas (University CEU San Pablo) ;
Al-Ahmad, Mona (Al-Rashed Allergy Center) ;
Abdul Latiff, Amir Hamzah (Pantai Hospital Kuala Lumpur. Allergy & Immunology Centre) ;
Ansotegui, Ignacio J. (Hospital Quironsalud Bizkaia) ;
Bachert, Claus (Karolinska University Hospital and Karolinska Institutet (Suècia)) ;
Baharuddin, Abdullah (Universiti Sains Malaysia. School of Medical Sciences) ;
Bergmann, Karl-Christian (Humboldt-Universität zu Berlin) ;
Bindslev-Jensen, Carsten (Research Center for Anaphylaxis (ORCA)) ;
Bjermer, Leif (University Hospital) ;
Bonini, Matteo (Royal Brompton Hospital & Imperial College London. National Heart and Lung Institute) ;
Bosnic-Anticevich, Sinthia (Woolcock Emphysema Centre and Sydney Local Health District) ;
Bosse, Isabelle (Allergist) ;
Brough, Helen A. (King's College Hospital NHS Foundation Trust) ;
Brussino, Luisa (University of Torino & Mauriziano Hospital) ;
Calderon, Moises A. (Imperial College and National Heart and Lung Institute) ;
Caraballo, Luis (Foundation for the Development of Medical and Biological Sciences (Fundemeb)) ;
Cardona, Victoria (Hospital Universitari Vall d'Hebron. Institut de Recerca) ;
Carreiro-Martins, Pedro (Comprehensive Health Research Center (CHRC). CEDOC. NOVA Medical School) ;
Casale, Thomas (University of South Florida) ;
Cecchi, Lorenzo (USL Toscana Centro) ;
Cepeda Sarabia, Alfonso M. (Asma e Immunologia. SLaai, Sociedad Latinoamericana de Allergia) ;
Chkhartishvili, Ekaterine (David Tvildiani Medical University-AIETI Medical School) ;
Chu, Derek K. (McMaster University. Departments of Medicine and Health Research Methods) ;
Cirule, Ieva (University Children Hospital. Latvain Association of Allergists) ;
Cruz, Alvaro A. (Federal University of Bahia and GARD/WHO Planning Group. Fundação ProAR) ;
Czarlewski, Wienczyslawa (Medical Consulting Czarlewski) ;
Del Giacco, Stefano (University of Cagliari. University Hospital "Duilio Casula") ;
Demoly, Pascal (Sorbonne Université. Equipe EPAR - IPLESP) ;
Devillier, Philippe (Université Paris Saclay. Pôle des Maladies des Voies Respiratoires, Hôpital Foch) ;
Dokic, Dejan (University Clinic of Pulmology and Allergy) ;
Durham, Stephen L. (Imperial College London. National Heart and Lung Institute) ;
Ebisawa, Motohiro (NHO Sagamihara National Hospital) ;
El-Gamal✝, Yehia (Ain Shams University. Children's Hospital) ;
Emuzyte, Regina (Vilnius University. Clinic of Children's Diseases) ;
Gamkrelidze, Amiran (National Center for Disease Control and Public Health of Georgia) ;
Fauquert, Jean Luc (Hopital Estaing. Pole pédiatrique. Unité d'Allergologie de l'Enfant) ;
Fiocchi, Alessandro (Bambino Gesù Children's Hospital) ;
Fokkens, Wytske J. (EUFOREA) ;
Fonseca, Joao A. (CUF Porto. Allergy Unit) ;
Fontaine, Jean-François (Allergist) ;
Gawlik, Radoslaw (Silesian University of Medicine) ;
Gelincik, Asli (Dışkapı Yıldırım Beyazıt Training and Research Hospital) ;
Gemicioglu, Bilun (Istanbul University-Cerrahpasa) ;
Gereda, Jose E. (Clinica Ricardo Palma) ;
Gerth van Wijk, Roy (Erasmus MC) ;
Gómez, R. Maximiliano (Instituto Medico Alas) ;
Gotua, Maia (Georgian Association of Allergology and Clinical Immunology. Center of Allergy and Immunology) ;
Grisle, Ineta (Center of Tuberculosis and Lung Diseases. Latvian Association of Allergists) ;
Guzmán, Maria-Antonieta (University of Chile. Clinical Hospital) ;
Haahtela, Tari (Helsinki University Hospital (Finlàndia)) ;
Halken, Susanne (Odense University Hospital. Hans Christian Andersen Children's Hospital) ;
Heffler, Enrico (Humanitas University) ;
Hoffmann-Sommergruber, Karin (Medical University of Vienna) ;
Hossny, Elham (Ain Shams University. Children's Hospital) ;
Hrubiško, Martin (Oncology Institute of St Elisabeth) ;
Irani, Carla (Hotel Dieu de France Hospital. St Joseph University) ;
Ivancevich, Juan Carlos (Clinica Santa Isabel) ;
Ispayeva, Zhanat (Kazakhstan Association of Allergology and Clinical Immunology) ;
Julge, Kaja (Tartu University Hospital (Tartu, Estònia)) ;
Kaidashev, Igor (Ukrainina Medical Stomatological Academy) ;
Kalayci, Omer (Hacettepe University School of Medicine) ;
Khaitov, Musa (Laboratory of Molecular Immunology. Federal Medicobiological Agency. Institute of Immunology) ;
Klimek, Ludger (Center for Rhinology and Allergology) ;
Knol, Edward (University Medical Center Utrecht) ;
Kowalski, Marek L. (Medical University of Lodz. Healthy Ageing Research Center) ;
Kraxner, Helga (Semmelweis University. Head and Neck Surgery) ;
Kull, Inger (Södersjukhuset. Sach's Children and Youth Hospital) ;
Kuna, Piotr (Medical University of Lodz. Barlicki University Hospital) ;
Kvedariene, Violeta (Vilnius University. Clinic of Chest Diseases and Allergology. Institute of Clinical Medicine) ;
Kritikos, Vicky (Royal Prince Alfred Hospital) ;
Lauerma, Antti (University of Helsinki and Helsinki University) ;
Lau, Susanne (Charité - Universitätsmedizin Berlin) ;
Laune, Daniel (KYomed INNOV) ;
Levin, Michael (University of Cape Town) ;
Larenas-Linnemann, Desiree E. (Médica Sur Clinical Foundation and Hospital) ;
Lodrup Carlsen, Karin C. (University of Oslo. Institute of Clinical Medicine) ;
Lombardi, Carlo (Fondazione Poliambulanza) ;
Lourenço, Olga M. (University of Beira Interior. Health Sciences Research Centre. Faculty of Health Sciences and CICS - UBI) ;
Mahboub, Bassam (Rashid Hospital) ;
Malling, Hans-Jørgen (University of Copenhagen. Danish Allergy Centre) ;
Manning, Patrick (Bon Secours Hospital (Dublin, Irlanda)) ;
Marshall, Gailen D. (Laboratory of Behavioral Immunology Research. Division of Clinical Immunology and Allergy) ;
Melén, Erik (Södersjukhuset. Sach's Children and Youth Hospital) ;
Meltzer, Eli O. (Allergy and Asthma Medical Group and Research Center) ;
Miculinic, Neven (Croatian Pulmonary Society) ;
Milenkovic, Branislava (Serbian Association for Asthma and COPD) ;
Moin, Mostafa (Tehran University of Medical Sciences. Immunology and Asthma and Allergy Research Institute) ;
Montefort, Stephen (University of Medicine. Mater Dei Hospital Malta) ;
Morais-Almeida, Mario (CUF Descobertas Hospital) ;
Mortz, Charlotte G. (Odense University Hospital (Dinamarca)) ;
Mösges, Ralph (CRI-Clinical Research International-Ltd) ;
Mullol, Joaquim (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Namazova Baranova, Leyla (Russian National Research Medical University. Scientific Centre of Children's Health) ;
Neffen, Hugo (Center of Allergy, Immunology and Respiratory Diseases) ;
Nekam, Kristof (Hospital of the Hospitaller Brothers in Buda) ;
Niedoszytko, Marek (Gdańsk. Medical University of Gdańsk) ;
Odemyr, Mikaëla (European Federation of Allergy and Airways Diseases Patients' Associations) ;
O'Hehir, Robyn E. (Alfred Health, Melbourne) ;
Ollert, Markus (Odense University Hospital. Odense Research Center for Anaphylaxis (ORCA)) ;
O'Mahony, Liam (University College Cork. APC Microbiome Ireland) ;
Ohta, Ken (Tokyo National Hospital. National Hospital Organization) ;
Okamoto, Yoshitaka (Chiba University Hospital) ;
Okubo, Kimi (Nippon Medical School) ;
Pajno, Giovanni B. (University of Messina. Allergy Unit) ;
Palomares, Oscar (Complutense University of Madrid. School of Chemistry) ;
Palkonen, Susanna (Charles University. Faculty of Medicine in Hradec Králové) ;
Panzner, Petr (Charles University. Faculty of Medicine in Hradec Králové) ;
G. Papadopoulos, Nikolaos (University of Manchester. Royal Manchester Children's Hospital. Immunity & Respiratory Medicine) ;
Park, Hae-Sim (Ajou University School of Medicine) ;
Passalacqua, Giovanni (Ospedale Policlino San Martino -University of Genoa. Allergy and Respiratory Diseases) ;
Patella, Vincenzo ("Santa Maria della Speranza" Hospital. Agency of Health ASL Salerno. Division of Allergy and Clinical Immunology) ;
Pawankar, Ruby (Nippon Medical School) ;
Pham-Thi, Nhân (IRBA (Institut de Recherche bio-Médicale des Armées)) ;
Plavec, Davor (University J.J. Strossmayer. Children's Hospital Srebrnjak, Zagreb) ;
Popov, Todor A. (University Hospital 'Sv Ivan Rilski') ;
Recto, Marysia (UP-PGH. Section of Allergy and Immunology) ;
Regateiro, Frederico S. (University of Coimbra. CIBB. ICBR - Coimbra Institute for Clinical and Biomedical Research) ;
Riggioni, Carmen (Institut de Recerca Sant Joan de Déu) ;
Roberts, Graham (Salford Royal NHS Foundation Trust NHS England North) ;
Rodriguez-Gonzales, Monica (Hospital Angeles Pedregal. Pediatric Allergy and Clinical Immunology) ;
Rosario, Nelson (Universidade Federal do Paraná) ;
Rottem, Menachem (Technion - Israel Institute of Technology. Rappaport Faculty of Medicine) ;
Rouadi, Philip W. (Eye and Ear University Hospital) ;
Ryan, Dermot (University of Edinburgh. Medical School) ;
Samolinski, Boleslaw (Medical University of Warsaw. Allergology and Immunology) ;
Sanchez-Borges✝, Mario (Centro Medico-Docente La Trinidad) ;
Serpa, Faradiba S. (Santa Casa de Misericórdia of Vitória-Espírito Santo. Asthma Reference Center - Escola Superior de Ciencias) ;
Sastre, Joaquin (Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz) ;
Scadding, Glenis K. (University College London. The Royal National ENT Hospital) ;
Shamji, Mohamed H. (Imperial College London. Allergy and Clinical Immunology) ;
Schmid-Grendelmeier, Peter (University Hospital Zurich (Suïssa)) ;
Schünemann, Holger J. (McMaster University. Departments of Medicine and Health Research Methods) ;
Sheikh, Aziz (The University of Edinburgh. The Usher Institute of Population Health Sciences and Informatics) ;
Scichilone, Nicola (University of Palermo. PROMISE Department) ;
Sisul, Juan Carlos (Clinica Sisul, Allergy & Asthma. Sociedad Paraguaya de Alergia Asma e Inmunologıa) ;
Sofiev, Mikhail (Finnish Meteorological Institute (FMI)) ;
Solé, Dirceu (Federal University of São Paulo. Division of Allergy, Clinical Immunology and Rheumatology) ;
Sooronbaev, Talant (Euro-Asian Respiratory Society. Kyrgyzstan National Centre of Cardiology and Internal Medicine) ;
Soto-Martinez, Manuel (Universidad de Costa Rica. Hospital Nacional de Niños. Division of Respiratory Medicine) ;
Soto-Quiros, Manuel (Hospital Nacional de Niños) ;
Sova, Milan (University Hospital Olomouc (Olomouc, República Txeca)) ;
Schwarze, Jürgen (The University of Edinburgh. Child Life and Health. Centre for Inflammation Research) ;
Skypala, Isabel (Royal Brompton and Harefield NHS Foundation Trust) ;
Suppli-Ulrik, Charlotte (University of Copenhagen. Institute of Cinical Medicine) ;
Taborda-Barata, Luis (Covilhã. University Hospital Centre) ;
Todo-Bom, Ana (University of Coimbra. Faculty of Medicine) ;
Torres, Maria J. (Instituto de Investigación Biomédica de Málaga) ;
Valentin-Rostan, Marylin (Allergist) ;
Tomazic, Peter-Valentin (Medical University of Graz. ENT-University Hospital Graz) ;
Valero, Antonio (Institut d'Investigacions Biomèdiques August Pi i Sunyer) ;
Toppila-Salmi, Sanna (Helsinki University Hospital (Finlàndia)) ;
Tsiligianni, Ioanna (International Primary Care Respiratory Group IPCRG) ;
Untersmayr, Eva (Medical University of Vienna. Center of Pathophysiology, Infectiology and Immunology. Institute of Pathophysiology and Allergy Research) ;
Urrutia-Pereira, Marilyn (Universidade Federal dos Pampa) ;
Valiulis, Arunas (European Academy of Paediatrics (EAP/UEMS-SP)) ;
Valovirta, Erkka (Terveystalo Allergy Clinic) ;
Vandenplas, Olivier (Université Catholique de Louvain. Centre Hospitalier Universitaire UCL Namur) ;
Ventura, Maria Teresa (University of Bari Medical School) ;
Vichyanond, Pakit (Mahidol University. Siriraj Hospital. Faculty of Medicine) ;
Wagenmann, Martin (Universitätsklinikum Düsseldorf) ;
Wallace, Dana (Nova Southeastern University, Fort Lauderdale) ;
Walusiak-Skorupa, Jolanta (Nofer Institute of Occupational Medicine) ;
Wang, De Yun (National University of Singapore) ;
Waserman, Susan (McMaster University (Canadà)) ;
Wong, Gary W. K. (Shatin, New Territories. The Chinese University of Hong Kong. Prince of Wales Hospital) ;
Yorgancioglu, Arzu (Celal Bayar University) ;
Yusuf, Osman M. (The Allergy and Asthma Institute) ;
Zernotti, Mario (Universidad Nacional de Villa Maria. Universidad Católica de Córdoba) ;
Zhang, Luo (Beijing Institute of Otolaryngology) ;
Zidarn, Mihaela (University Clinic of Respiratory and Allergic Diseases (Golnik, Eslovènia)) ;
Zuberbier, Torsten (Humboldt-Universität zu Berlin) ;
Jutel, Marek (ALL-MED Medical Research Institute) ;
Universitat Autònoma de Barcelona
2021 - 10.1002/clt2.12014
Clinical and translational allergy, Vol. 11 (june 2021)
|
|
10.
|
18 p, 2.6 MB |
Efficacy of systemic oncological treatments in patients with advanced esophageal or gastric cancers at high risk of dying in the middle and short term : an overview of systematic reviews
/
Santero, Marilina (Institut d'Investigació Biomèdica Sant Pau) ;
Bracchiglione, Javier (Universidad de Valparaíso) ;
Acosta-Dighero, Roberto (Universidad San Sebastian) ;
Meade, A. G. (Institut d'Investigació Biomèdica Sant Pau) ;
Antequera, Alba (Institut d'Investigació Biomèdica Sant Pau) ;
Auladell-Rispau, Ariadna (Institut d'Investigació Biomèdica Sant Pau) ;
Quintana, M. Jesús (Universitat Autònoma de Barcelona. Facultat de Medicina) ;
Requeijo, Carolina (Institut d'Investigació Biomèdica Sant Pau) ;
Rodríguez-Grijalva, G. (Institut d'Investigació Biomèdica Sant Pau) ;
Salas-Gama, Karla (Institut d'Investigació Biomèdica Sant Pau) ;
Dorantes-Romandia, R. (Institut d'Investigació Biomèdica Sant Pau) ;
Salazar, Josefina (Institut d'Investigació Biomèdica Sant Pau) ;
Solà, Ivan (Institut d'Investigació Biomèdica Sant Pau) ;
Urrútia, Gerard (Institut d'Investigació Biomèdica Sant Pau) ;
Bonfill, X. (Xavier) (Institut d'Investigació Biomèdica Sant Pau)
Esophageal and gastric cancers are a significant public health problem worldwide, with most patients presenting with advanced-stage disease and, consequently, poor prognosis. Systemic oncological treatments (SOT) have been widely used over more conservative approaches, such as supportive care. [...]
2021 - 10.1186/s12885-021-08330-5
BMC Cancer, Vol. 21 (june 2021)
|
|